facebook. feels like it's breaking out. we had the upgrade today. pete talked about it. tim. stevie. fbook through 85 bucks. >> i'm mandy drury. catch "fast money" again 5:00 p.m. right now. my mission is simple. to make you money. i'm here to level the playing field for all investors. there is always a bull market somewhere. and i promise to help you find it. mad money starts now. >> hey, i'm cramer. back to mad money. kra mer kah. my job is not understanding but the teach and coach you. call me 1800 cnbc or tweet me me @jimcramer.

when we stop fretting about greece what shines through is a core group of very strong stocks, good fundamentals that can go higher. either because they are relative relatively cheap or have tremendous growth. let's brake it down. the disney's latest quarter, fantastic, good numbers from every division. especially espn theme parks and movies. and shanghai disney opens in 2016, yet another reason for estimates to go higher. disney is bid up because it has superior growth in a world where it's hard to find. the quintessential stock for this moment. so are two others. starbuck's and nike. starbuck's spent most of the day moving higher has hit a

consistent level of growth with acceleration in both u.s. and china. why? because of new technology that increases throughput allowing more people to get their coffee fix in a shorter period of time. nike is just doing extraordinarily well. and if greece is soft you will see the dollar go lower versus the euro giving nike's earnings a nice boost. second book is the banks. when greece's stocks get better our interest rates go higher. causing bond prices to fall and thus bond yields to rise. when rates go higher banks make money off your deposits. the winner wells fargo and j.p. morgan as they stand to make a killing. even if rates remain at these levels, the comparisons will get easy and that will really get this very inexpensive group going. and given that the financials are the largest segment in the

s&p 500, well what can they say? it bodes well for the broader mark. tech also does better. the internet of things and social mobile and cloud revolution. the current group is driven by consolidation in the semi-conductor. nxpi. and others. all about connecting car, homes, information, video computers in ways that didn't seem possible not that long ago. these companies all have tremendous earnings momentum and i like them very much. but other tech winners, obvious ones, apple, facebook breakout. amazon netflix breakout. and google. all companies that get hit but a strong dollar and weakness in europe. so these companies overseas profits will translate into more greenbacks as last. and bravo to apple for quickly changing its mind when the biggest star in the galaxy

taylor swift stood up to them on not paying royalties during the trial period. she comes out against apple and they tweet she's right. no lawyers. no drawn out courtroom drama. problem solved. wow this is the way america should be. now expect apple to check mait quickly. because of all the attention by it. and we continue to see breakthrough after breakthrough reverberating through the system. this morning epizoan announced for relapsed non hodgkin's lymphoma. next thing you know celgene is

rallying. so many drug approvals in the sector. think of the next generation of cholesterol drugs. market is huge. consider the tremendous data on alzheimer's. gilead keeps hitting new highs. let's not forget how good the junior bio techs can be like receptos. ground breaking drug that can treat frefrg multiple sclerosis bowel conditions are and crohn's disease. or bio jumping another for radius health which is catapulting another 5% and they are going to be on the show. these drugs are working. that is why the stocks are moving. because these are successes. and there are far fewer failures in bio tech. the strilss can lev state here.

these companies have been totally hostage to a potential european slow down as well as the weak euro. with greece settled we can -- let's say we hope for better than expected guidance even if the actual quarters won't be that good. that's already baked in. look, same goes for the consumer package good stories and power plays hobbled by the strong dollar and the weakness in europe. i can't tell you how much these stories have been distorted by the strong dollar. it's been a nightmare. people are taking time to smell the roses in housing because enough time has now passed since the great recession that home sales have improved and won't be crushed by higher interest rates in my view. the level of household formation in this country after averaging about 500,000 new families a year since 2007 is now having an

employment-related boom. we're going to have 2 million new households. employment related boom is causing 2 million. never underestimate the power of growth and first time home buyers. they are the one who shop to fix up their places and get cloetds and housewares. household formation will trump any rise in interest rates because people with jobs don't want to keep living with their parents. and we saw anthem bidding for signature. and the equity going after williams. and the companies want growth. it is easier to drill on wall street than it is to prospect in the permian. anthem can cut costs a couple billion dollars and gain instant scale just by acquiring cigna.

and allergan, buying thur last week. and the moment the greek deal is done and we get stabilization in europe that will be the federal reserve's chance to take action. you know i am concerned about this short-term. i have to tell you once greece is solved they won't upset the international apple cart when they say they are going to raise. it will be have benign back drop of good employment growth and retail and not to mention all the issues mentioned above which will make it very easy to raise rates. when it initially happens will cause a selloff. which is why i've been doing the healthcare hot list but it won't be a long sell of you.off. all of this good news been understated by europe. we spent a lot of time on europe because europe spends a lot of time influencing the money managers with big pools of capital in this country.

when europe is out of the spotlight you can see what's happening here. and for the bulls it is a beautiful thing. how about curtis in louisiana. >> caller: hey jim. how you doing? >> really good. how about you partner. >> >> caller: great. in baton rouge, louisiana. >> i love there. and it's some pretty good football down there. >> >> caller: pretty good food too. in april, american ally was about $48. beginning of june 38. and today about 3. would you buy aa at this time? or another airline stock? >> i think delta is cheaper. i think delta is the better buy for the moment. but understand these stocks are going -- they are having a rally ahead of the quarters which are in the second last week of july. they will sell off when the

quarters happen and then go quickly up again. buy some now and buy some after the numbers get cut when they report the quarter. but this is the bottoming action i really really like. how about beth in texas. >> caller: hi jim. i'm interested in hearing about unisar. they just went back on to public trading. they had their ipo same day as fit bit. i'm in them but i'm not seeing any analysis or much reporting on them. i'm curious do you see this as the long-term prospect? or would it be better to take the short-term gain and get out. >> you know i think it is long-term. i did the work on them because they were there ringing the bell and i said wow this is an inexpensive company with a lot going for it. i think you have a lot going there. a lot of criticism for being right on twitter this week and quitting fit bit. and people were furious i got it

right. that's okay. you can't serve everybody. the good news has always been in the u.s. and we saw it today when the market decided to shake off europe's dilemmas. and it is a beauty? honestly. and i'll unveil a power house when i add to it my healthcare hot list. and what are we supposed to do with the company inside go pro's body cameras and drones is down big today. should you eliminate it or will it record another rally. and my season of radius health department, a stock soaring 60% this year. stick with cramer.

you probably know xerox as the company that's all about printing. but did you know we also support hospitals using electronic health records for more than 30 million patients? or that our software helps over 20 million smartphone users remotely configure e-mail every month? or how about processing nearly $5 billion in electronic toll payments a year? in fact, today's xerox is working in surprising ways to help companies simplify the way work gets done and life gets lived. with xerox, you're ready for real business.

(engines revving) listen up. ready. ready. (engines revving) steady. (engines revving) go! ♪ ♪ ♪ ♪ it's more than a movie. it's now a ride. fast and furious. supercharged. ride it at universal studios hollywood.

keep telling you the big picture. we could be in a bit of a lose lose situation in a few weeks. if there is no greek deal then europe goes down and so to do we. but if there is a solution then after a nice rally, some of which we're stealing from right now immediately the fed heads are going to start talking about how we need a rate hike asap. and the more cautious members of the federal reserve will no longer be able to use europe as the reason to hold off tightening. either way euro stock market could get a bit of a hit. and if the fed is too aggressive we might experience a slow down in the economy. i personal think they will raise slowly and gradually and be responsible and once greece is past we'll be find. however my view is in the minority as most managers believe that any rate hike will be toxic. that is why for weeks i've been stressing the need to own secular growth stocks meaning the kind of companies that put up consistent results regardless how the economy is doing.

in particular the healthcare cost containment plays. because i think controlling healthcare costs is one of the great secular growth stories f our era. all month i've been introducing the hot list. my favorite 12 healthcare cost containment. the pharmacy, the drug distribution companies, i've mentioned by favorite pharmacy benefit manager. express scripts. and we're going with the real action is. insurance providers and health maintenance organizations, a group where you have seen frantic activity as of late with rumors of more potential deals to come. first humana and now appears that it that is getting hot and heavy with humana. and and anthem wants cigna. and cigna rejected yesterday. i found myself thinking thank

heavens i am not an investment banker. it is hard to keep the players straight here but at the end of the day it feels like everybody is trying to buy everybody in this space. i feel safe in saying any consolidation will be good for the group because with each acquisition that is one more competitor taken out of the picture. so tonight i want to talk to you about the colossus in the industry united health group. unh for home gamers. two businesses. united healthcare which is the largest provider in the u.s. and then the secret sauce, optem which is part pharmacy benefit manager. part software advisory consulting and business process outsource ugh. the stock of unh has been on a fabulous streak. up nearly 19 percent year to date. almost 50 percent over the past

12 month. 86% over the last 2 years. and monstrous, 2005% gain over the last five years. secular growth. obamacare, the truth is the bill was written by the insurance companies and hmos. it is now the law of the land you have to buy health insurance or take a big hit during tax time. 59 million people across the united states. and think expect to had even more policy holders. the company has used careful analytics to create a line of products to attract consumers and make them money. and in addition is medicare medicaid and military healthcare plans and steadily growing enrollment and revenues. the really exciting part of the unh is the faster growing optum.

providing services are iffor 32 million nationwide. helping --. by identifying the most cost effective treatments and buying them in bulk. unh believes optum has a 500 billion dollar addressable market. not many companies have that size market. and they expect sales to grow by 9% this year. and back at the end of march unh announced optem would be acquiring catamaran. and a transaction is expected to close in the fourth quarter. after this quarter they will have the third largest growth in the u.s. express scripts fills 1.3 billion precipitations annually. and after this deal they will be

fulfilling roughly 1 billion per year. that is huge. and unh's management believes this deal could boost earnings per share by 30 cents and combined catamaran optem entity could account for 40 percent of earnings over the next few years. and their contract is pretty much ironclad through 2023. it is unlikely acquired by anthem will cause to lose that. and most recently the company signed up doctor on demand. which we recently featured. virtual doctors appointments allowing them to significantly cut down on the custody of inperson visits. in april they knocked it out of the parked. delivering earnings increased by

32% year over year. in fact if first quarter lone unh added --. management gave robust higher than expected sales and earnings guidance. in short, even though unh has been on a role that is because the company has been at the top of its game and while we don't know whether they will end you will being able to acquire a competitor, we do know any takeovers means fewer competitors and less competition is always a good thing for business. maybe not you. maybe not your company. for unh, yes. right now unh trades roughly 17 times next year's estimates which means a slight premium debt. however in my view they are the best player here. which means it deserves to trade there. and that is kind of conservative considering what they could be trading at. and at a moment when unh is

trying to buy aetna and it that wants anthem and anthem is trying to snap up cigna, unh is the biggest titan. and one of the few with the scale the balance sheet and diversity of the business to easily make any acquisition it might want to. compared to unh the other players in the group are basically sitting ducks and while nobody is going to acquire unh -- it is too big -- they are a best of breed operator making the right decisions to keep growing. including the recently very smart catamaran deal. even though they are trading just 3 bucks off highs, i think it is a buy buy buy. much more mad money ahead including my take on the crazy action in ambarella. don't edit your position on this stock nulluntil you get my take. and then it is up 60% year to date. and only i have the ceo.

do not miss my exclusive with radius health. activists, takeovers and twitter. oh my. stick with cramer.

can you believe this frantic

action in anmbarella? they are a semi-conductor company that makes chip for the high definition capture market. they make the brains inside the go pro. but their chips also have a lot of other uses drones surveillance connected cars and police body cameras, among a host of other uses just being dreamed up now. ambarella -- and then the stock ran some more after the company managed to blow away the numbers. as of friday they were trading at $127. up roughly 150% year to date. whenever relatively new stock has such an enormous run the critics are bound to start crawling out of wood work screaming it is overvalued. sure enough, they got hit with a negative note on friday from the professional bears at sit ron

research which called the stock ridiculously overvalued and said it deserved to trade down 60. since that note on friday ambarella has gone into a free fall losing more than 30 points in two sessions. including a hideous nearly 20% bell ringer today. at this point the stock has erased virtually all of its gains since ambarella reported that terrific quarter earlier this month. ursa major one, taurus nothing. at this moment those at ambarella would trade it for a poster of the barbrella. we need to ask whose right? the are bears correct meaning the decline makes sense? or do the bulls have a better argument in which case today's horrible pullback could be a

terrific buying opportunity? let's look closer. they develop a low power high definition computer chips for tons of applications. the most obvious the part of the go pro's wearable cameras. but it wasn't the concept that got people interested in ambarella. it was the numbers. they have been spectacular. they have had years of arrrggh accelerated revenue growth. and something they expect to continue. and in 2015 fiscal year they racked up 38.5% sales growth and the current year they are expecting 48.6%. those are incredible figures. especially since we know that money managers on wall street will pay fortune for companies with accelerating revenue growth because they are so few and far between. meanwhile the margins have been

expanding and resulting in explosive earnings growth. on the other hand though ambarella stock price, well let's just say it's been appreciating like crazy at least until the past couple sessions. came public in october 2012. at the end of last year 50 and as of last friday it had got up to $127. at the close friday trading 38 times earnings estimates. not exactly super cheap. although after today's pasting they sell for just 30 times the 2016 numbers. that makes it less expensive and high growth addicts would actually use the term "reasonable." so with all that in mind let's go through the bull case and then the bear case.

a little harder to make, starting with the bear case because today the bears ascended. three key points the negatives believe it will become a victim of the commoditization in the semi-conductor space. and they think it's too closely aligned with go pros. and third they believe ambarella's valuation is out of control. that argument carried a lot more weight before today's selloff. so let's go through the points one by win. at for commoditization in the semi conductor group, we know a big problem for companies with low end chips like sandisk or micron have been crushed but basically because their products are commodities to begin with. ambarella makes high end chips and the company continues to innovate and introduce better quality technology on ever smaller chips that use less and less power. the bears would counter the superior technology really only

gives them a 6 to 9 month lead on the competition. then there is the complaint that ambarella is too closely aligned with gopro. legitimate argument. because you never want too much sales from one customer and right now gopro is a gigantic portion of the business. however they have been pointing out all the ways they have been diversifying and into new markets, particularly drones. and you could argue gopro needs ambarella at least such as ambarella needs gopro. as for the bears i think it was a lot more legitimate last week but not after this massive selloff. and the bull case? simple boils down to they make the best product. end markets including home security. and it deserves to trade at the

premium to the average semi conductor stock. most don't have earnings growth. and ambarella could easily be a takeover candidate, perhaps by the very needy needing to diversify, equalqualcomm. -- the bulls are adamant that this story is about more than just gopro. they offer high class solution s for new cars. body cams. and most importantly surveillance drones. for better or worse, a world with more drones is a world where where they are selling a ton of chips. expected to grow earnings at 55% clip this year.

my view. okay i've been a fan of ambarella. but even i can acknowledge that the stock's price had gotten high. and the last play was roughly the shorts throwing in the towel. still in wake of this selloff i think ambarella has become a rapid grower. it is now too inexpensive to ignore. that is right. i think after today you are basically getting the company's most recent spectacular quarter for free at these levels. yes they had a move to the upside that brought out passionate voices on the bullish and bear side. but the one thing that is not arguable is the valuation has changed dramatically over the last two sessions and these lower levels give you a terrific entry point. i believe in the long-term ambarella story and if you have missed the run you know what

you may just have gotten a chance to get in ambarella at a much more reasonable price than you could last thursday. asheesh in massachusetts. >> caller: booyah jim. i'm a great fan. my question is the pasr. i've owned it for ten years. it hasn't gone anywhere except the past --. my question is i'm curious about the long-term outlook based on the pipelines fundamentals and leadership in the institution and what is your opinion on any m and a activity? >> i don't know about m and a because then i'm speculating well beyond my pay grade. but it is an ecosystem. we know that because we had the ceo rick smith on. i like the stock.

and i've continued to like it. i've liked it since the teens. but you know what? i think ambarella is red hot. you miss the run? have no fear you are getting a good entry point. after this decline i do have to side with the bulls. @jimcramer or twitter. already i'm hated. and much more. man behind one of the hottest stocks in the market right now. radius stocks. i've got the ceo. and snoop dogg wants to be the next ceo of twitter. i'll tell you why it will take much more to get that stock higher. and plus your calls. rapid fire in a brand new edition of the lightning round. stick with cramer.

look at radius health roar. a development stage bio tech that's been flying courtesy of very strong data announced last week. we're big fans of radius which develops drugs for osteoporosis and other endocrine-mediated disorders. on fire for ages rallying 380% in 2014. when we last spoke to the ceo in

may after an industry wide selloff, since then the stock gave us another phenomenal 66% gain. the latest leg up for them comes because they announced very positive data for the main osteoporosis drug. it is currently in phase 3 trials. helps bone growth and prevent bones from breaking in osteoporosis. and significantly better than the current standard of care. and the doctor who led the development of eli lilly is now on the board of directors for here. let's check with the president and ceo of radius health. good to see you sir. >> good to see you as well. >> results are astonishing. and describe these for vertebrae and the rest of the body how

much better this is than the current standard. >> we did two trials. the active trial which is 18 months of bone building. and then the active extend which is a maintain trial. so build, and then maintain. the group on the drug for 18 months experienced no vertebral fractures in the six months. >> none. >> none. >> which is kind of game set, match versus whatever else you are taking but we have to wait for side effects. the science is kind of proved by that. >> it is. because the mechanism of action is well understood. we have a unique signaling. so as a result we liberate less calcium. in the active trial we pre specified hypercalcemia and had statistically less so we understand the full profile. but the new vertebral data and also non vertebral. major osteoporotic fractures. clinical fractures, we hit on each one with the new drug.

quite exciting. >> fort eo 7.4, you are 8.2. 2% and 7%. that is a dramatic difference in terms of growth. >> the amount of bone, where we build bone and the time course of the bone build makes a big difference how patients benefit from different osteoporosis therapies. >> right. now also there is a difference in the way it can be given. one of the things i was trying to understand why does refrigeration matter. one has to be refrigerated the other doesn't. >> well this is a peptide. so yes the forteodrug is kept in the refrigerator. we believe the data suggests when it is at the patient's home they may not have to refrigerate the drug. >> i think that is big. ultimately you are talking about elderly people who unfortunately get to the hospital with a broken bone and can't go to rehab and then end up dying because of something that your drug might prevent from the

beginning. >> well jim, the amazing part is a lot of times osteoporosis is thought of as disease as the elderly because yes, hip fracture hp happens when you are 70 or 80. but wrist fracture vertebral fractures, this happens when you are 50. in fact as we've talked to individuals, we'll find out people are playing tennis. they fell and broke their wrist and find out they had osteoporosis for the first time. so intervening earlier can help avoid those devastating fractures of the elderly you were speaking of before. >> arnett aren't you talking about something conceivable, if everything goes right, 2016. >> we are on track for submission of the mva in the u.s. this year and maa as well. and 2016 ideally would be first commercial sale, yes. >> and the gentlemen involved with forteowould not have i assume to radius's board of directors if he didn't feel this

could be a major drug. >> all of us when we saw the latest round of data took a step back and said wow. >> it came out. and the stock hung there initially. and i said no this is much better than what i was looking for. and let's talk for a moment about your other drug. a breast cancer drug that is also involved for menopause. this again something people want to have -- eliminate hot flashes. but there's been side effects. your drug has fewer apparently. >> right. it is just part of our pipeline. for 1901 we previously completed a phase 2 study and showed significant reduction of vas motor systems and right now we have a phase one trial in metastatic breast, enrolling and dosing patients as we speak. and this year beerwe're looking to start phase 2 b. >> arguably considered as big as the osteoporosis drug. >> yeah. the opportunity, the medical

need in vaso motor systems is substantial. >> most companies are lucky to have one that is two or three years ago. you have two that are closes. remarkable story. thank you so much. >> excited to be here. >> babbpresident and ceo of radius health. you can see everything is help. this is the most disclosed story. monumental breakout figures. check it out.

[dad]i wear a dozen different hats doing small gigs,side gigs...gig gigs. quickbooks self-employed helps me get ready for tax time. to separate expenses,i just swipe. it's one hat i don't mind wearing. [passenger] i work for me. and so does quickbooks. it estimates my taxes,so i know how much stays in my pocket. and that's how i own it. [announcer]stay in the flow with quickbooks self-employed. start your free,thirty-day trial today at join-self-employed-dot-com.

it is time. time for lightning round.

and then the lightning round is over. are you ready. and time for the lightning round. edgar edgar. >> caller: it's a honor to talk to you. >> thank you. >> caller: i want to give you porky pig. [inaudible] >> i like that. >> caller: and my stock is onty health. >> everyone is saying it ees's. i. >> shirley in florida. >> caller: how jim. it is about 85 degrees here today. a little cooler for a change. we've been up to 105. >> i hear that lately. go ahead, yeah. >> caller: i want to know about agnc. do i buy more. >> i don't want you in that. i think that is a bad situation. i don't like that yield. i think it is a yellow and red

flag together. pete in illinois. pete. >> caller: hi jim. big blackhawks booyah from the stanley cup champion city of chicago. >> major winner booyah. >> caller: lied i'd like your insight on agios. >> we played this to the hill. it was a great, great trade. kevin. >> caller: thanks for taking my call. please keep in mind that kender morgan is a big holder in my portfolio. but what do you think of the mark west. >> a great play on the marcellus and the ute kah. i think you can get it a the 6% yield. yield is 5.9 right now. it is worth waiting. >> caller: the matrix company. >> i have no idea why they said no to that bid and the stock has

been sinking ever since. and i say don't buy until it gets to 4% yield. one more in luis in north carolina. >> caller: booyah jim. >> right back at you. >> caller: this is like an entire kra mercramerica by itself. my --. great pipeline of products for the holiday season. game stop. >> game stop is so inexpensive. it is gaffing. everybody is short it as it should because that gamecompany has game. doug. you've been staring at that for a while, huh? listen, td ameritrade has former floor traders to help walk you through that complex trade. so you'll be confident enough to do what you want. i'll pull up their number. blammo. let's get those guys on the horn. oooo. looks like it is time

to upgrade your phone, douglas. for all the confidence you need. td ameritrade. you got this.

there are two kind of takeover targets right now, companies that can help the acquirers grow and companies with businesses that are good but not good enough to please activist shareholders. other than that there is not much room for deals. when i talk acquired growth i mean like anthem attempting to acquire cigna. there is a huge amount of duplication that goes away almost instantly. and plus more pricing discipline as the hmo industry has historically been prone to price wars. so this deal would give anthem a lot of growth it might want.

it beats spending a fortune or cutting prices to get more customers. i would put the anthem bid for 48 million dollars for williams in the same pipeline. could give instant growth. something desperately need t in a pipeline industry. there is the second kind of takeover though. jana in conagra. they can help make it a better company. for example wall grooens -- and i like jana in there pushing. but i they walgreens still would have done well. and same with dupont. and dow chemical. these kind of spurs make sense. they make a good situation better. now as positive as those resolutions were the home run outcome in these situations is an outright sale. i'm sure ultimately jana would

like to see conagra sell to a company lake kraft. either way jana is going to win. which leads me to twitter. no strong leader in the company right now. and the interim ceo isn't able to do much. you might think twitter could be an obvious target for activists. could easily buy percentage of the shares and advocate for change or a sale. however going after twitter would be at the odds of current ethos of angtctivists i just mentioned. they don't want to launch without a safety net right now. it is not like the activists are going to blow up the firm's performance if they fail to get their people elected and have a huge position that could sink on them. the stocks wouldn't fail all that much. even with dupont's only went down a little more than 4% from highs. hardly a disaster. but twitter?

i would argue that unless an activist can get twitter to sell itself, something that could happen, then this activist might lose a lot of money if they have trouble growing user base. despite protests that revenue growth is now the key metric and it is robust twitter could still get hammered if month average users go down. and that means that well frankly it is not the kind takeover target the activists are looking for. i think it is too high risk more most to take a shot at. doesn't mean the logical acquirers couldn't move. however they would want aen viet eninvite to make a bid. and i don't think current management will. the current crop of activists right now only one win-win situations and that is something twitter cannot provide, at least not yet. i think the activist takeover two step might not come to fruition at twitter any time soon. stick with cramer.

sometimes, at last doesn't happen at first. ♪ ♪ your dad just kissed my mom. ♪ turning two worlds into one takes love. ♪ helping protect that world takes state farm. why pause a spontaneous moment to take a pill? or stop to find a bathroom? cialis for daily use, is approved to treat both erectile dysfunction and the urinary symptoms of bph, like needing to go frequently, day or night. tell your doctor about all your medical conditions and medicines, and ask if your heart is healthy enough for sex. do not take cialis if you take nitrates for chest pain as it may cause an unsafe drop in blood pressure. do not drink alcohol in excess. side effects may include headache, upset stomach, delayed backache or muscle ache. to avoid long-term injury, get medical help right away for an erection lasting more than four hours. if you have any sudden decrease or

loss in hearing or vision or any symptoms of an allergic reaction stop taking cialis and get medical help right away. ask your doctor about cialis for daily use and a free 30-tablet trial. ♪ what if we finally had a backyard? that'd be amazing. ♪ hey, what if we took down this wall? ♪ what if this was my art studio? what if we were pre-approved? ♪ shut up. from finding, to financing. how'd you do that? zillow. hey, what are you doing? you said you were going to find out about plenti, the new rewards program.

i did. in fact, i'm earning plenti points right now. but you're not doing anything right now. lily? he's right. sign up, and you could earn plenti points just for being a wireless customer. in the meantime, i just kick back and watch the points roll in. where did you get those noodles? at&t cafeteria. you mean the break room... at&t - the only wireless carrier to be a part of plenti now when you add a new phone line to your wireless plan you get 5,000 plenti points to use in lots of places. ambarella, i thought it was down too much. radius health, not up enough yet. i have to tell you i think that radius health has not one but two block busters. you got to like that. i'm jim cramer and i'll see you tomorrow. soccer! top chef! disco.

the x1 voice remote from xfinity. [ wind howling ] >> at the edge of nowhere, only the wind and small talk break the silence. >> all right, boys. you have fun. >> one step behind you. >> the stillness lasts only a second. >> all smiles, baby. are you ready? >> and then, it is replaced by this. >> here we go. [ air whooshing ] >> the sound of a human body moving at 120 miles an hour. these are wingsuit base jumpers at work, riding the new high of